Tempus AI (TEM) Price/FCF Ratio: History & Chart

Tempus AI, Inc. (TEM)TEMTempus AI, Inc.

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Tempus AI, Inc. (TEM)	$7.49B	N/A	N/A	N/A	N/A
Oscar Health, Inc. (OSCR)vs ›	$7.49B	3.32	4.19	6.77	8.40
Hims & Hers Health, Inc. (HIMS)vs ›	$6.57B	84.58	83.07	72.08	72.08
Bio-Rad Laboratories, Inc. (BIO)vs ›	$8.63B	23.73	22.51	36.71	47.23
Henry Schein, Inc. (HSIC)vs ›	$9.76B	23.02	21.35	20.41	19.54
Universal Health Services, Inc. (UHS)vs ›	$10.16B	10.75	13.54	17.27	41.61
Walgreens Boots Alliance, Inc. (WBA)vs ›	$10.37B	17.86	17.13	29.64	17.62
Molina Healthcare, Inc. (MOH)vs ›	$10.50B	37.40	31.75	50.78	33.34
Charles River Laboratories International, Inc. (CRL)vs ›	$10.88B	28.35	17.74	22.36	28.03
Bio-Techne Corporation (TECH)vs ›	$11.24B	41.68	38.33	44.32	48.65

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Tempus AI, Inc. (TEM)

$7.49B

N/A

Oscar Health, Inc. (OSCR)vs ›

$7.49B

3.32

4.19

6.77

8.40

Hims & Hers Health, Inc. (HIMS)vs ›

$6.57B

84.58

83.07

72.08

Bio-Rad Laboratories, Inc. (BIO)vs ›

$8.63B

23.73

22.51

36.71

47.23

Henry Schein, Inc. (HSIC)vs ›

$9.76B

23.02

21.35

20.41

19.54

Universal Health Services, Inc. (UHS)vs ›

$10.16B

10.75

13.54

17.27

41.61

Walgreens Boots Alliance, Inc. (WBA)vs ›

$10.37B

17.86

17.13

29.64

17.62

Molina Healthcare, Inc. (MOH)vs ›

$10.50B

37.40

31.75

50.78

33.34

Charles River Laboratories International, Inc. (CRL)vs ›

$10.88B

28.35

17.74

22.36

28.03

Bio-Techne Corporation (TECH)vs ›

$11.24B

41.68

38.33

44.32

48.65

Price/FCF Ratio: N/A

TEM Price/FCF Ratio Metrics

TEM Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics